# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-17-014048
Filing Date
2017-03-10
Accepted
2017-03-10 17:26:39
Documents
25
Period of Report
2017-03-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | v461584_8k.htm | 8-K | 12962
2 | EXHIBIT 99.1 | v461584_ex99-1.htm | EX-99.1 | 25020
3 | GRAPHIC | image_001.jpg | GRAPHIC | 76951
4 | GRAPHIC | image_002.jpg | GRAPHIC | 111545
5 | GRAPHIC | image_003.jpg | GRAPHIC | 93411
6 | GRAPHIC | image_004.jpg | GRAPHIC | 63015
7 | GRAPHIC | image_005.jpg | GRAPHIC | 69274
8 | GRAPHIC | image_006.jpg | GRAPHIC | 60962
9 | GRAPHIC | image_007.jpg | GRAPHIC | 77747
10 | GRAPHIC | image_008.jpg | GRAPHIC | 88050
11 | GRAPHIC | image_009.jpg | GRAPHIC | 75936
12 | GRAPHIC | image_010.jpg | GRAPHIC | 80363
13 | GRAPHIC | image_011.jpg | GRAPHIC | 88563
14 | GRAPHIC | image_012.jpg | GRAPHIC | 94307
15 | GRAPHIC | image_013.jpg | GRAPHIC | 126770
16 | GRAPHIC | image_014.jpg | GRAPHIC | 80796
17 | GRAPHIC | image_015.jpg | GRAPHIC | 80852
18 | GRAPHIC | image_016.jpg | GRAPHIC | 67785
19 | GRAPHIC | image_017.jpg | GRAPHIC | 86838
20 | GRAPHIC | image_018.jpg | GRAPHIC | 69736
21 | GRAPHIC | image_019.jpg | GRAPHIC | 80292
22 | GRAPHIC | image_020.jpg | GRAPHIC | 68721
23 | GRAPHIC | image_021.jpg | GRAPHIC | 90849
24 | GRAPHIC | image_022.jpg | GRAPHIC | 75858
25 | GRAPHIC | image_023.jpg | GRAPHIC | 56623
| Complete submission text file | 0001144204-17-014048.txt |  | 2610935

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 17683175
SIC: 2836 Biological Products, (No Diagnostic Substances)